Table: Cosmos Pharmaceutical -Q1 group results

Cosmos Pharmaceutical

14/10/2025 07:30

Oct 14 (Reuters)- 
             Cosmos Pharmaceutical Corp. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Aug 31, 2025        Aug 31, 2024     May 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            272.39              261.84          1.06 trln  
                 (+4.0 pct)          (+8.4 pct)       (+4.5 pct)  
  Operating         11.65               11.58            40.50    
                 (+0.6 pct)          (+28.8 pct)      (+0.2 pct)  
  Recurring         12.19               12.29            43.20    
                 (-0.9 pct)          (+26.7 pct)      (+0.1 pct)  
  Net                8.17                8.14            31.00    
                 (+0.3 pct)          (+25.1 pct)      (+0.1 pct)  
  EPS            103.10 yen          102.74 yen       391.13 yen  
  Ann Div                             70.00 yen        75.00 yen  
  -Q2 div                             32.50 yen        37.50 yen  
  -Q4 div                             37.50 yen        37.50 yen  
  
  NOTE - Cosmos Pharmaceutical Corp.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T